French healthcare company Ipsen has agreed to buy U.S. peer Clementia Pharmaceuticals in a deal worth up to $1.31 billion, the companies said on Monday, helping to boost Ipsen's portfolio of products treating rare diseases.
https://ift.tt/2Smazwp support@endlesssupplies.biz (Endless Supplies .Biz) February 25, 2019 at 01:03AM
No comments:
Post a Comment